The Licensing Advisory Board (LAB) is a critical component of the business development process, furthering Paladin’s core capabilities in the sourcing and assessment of licensing and development candidates. The core mandate for the LAB is to ensure that Paladin is at the leading edge of scientific and clinical evaluation of acquisition and licensing candidates, resulting in an exciting and rich product portfolio and pipeline.

Our LAB members are:

Dr. Neil Fleshner MD, MPH, FRCSC
Head of the Division of Urology at the University Health Network in Toronto (incorporating Princess Margaret Hospital) and Associate Professor at the University of Toronto

Dr. David Hanley MD, FRCPC
Medical Director, Grace Osteoporosis Centre
Professor and Head, Division of Endocrinology and Metabolism
Department of Medicine
University of Calgary

Dr. Robert L. Reid MD
Professor, Department of Obstetrics and Gynecology and Chief, Division of Reproductive Endocrinology at Queen's University in Kingston, Ontario

Dr. Peter Thomson BSc (Pharm), PharmD
Clinical Pharmacist for Internal Medicine at Health Sciences Centre in Winnipeg Manitoba and Clinical Assistant Professor with the Faculty of Pharmacy at the University of Manitoba

Dr. Luc Valiquette MD, FRCSC
Full Clinical Professor in the Department of Surgery at the Universite de Montreal and Chief of Urology Department at the CHUM